UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q/A

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

 

For the quarterly period ended October 31, 2003

 

 

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT

 

 

 

For the transition period from             to            

 

 

 

Commission file number 000-29278

 

KMG CHEMICALS, INC.

(Exact name of registrant as specified in its charter)

 

Texas

 

75-2640529

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

10611 Harwin Drive, Suite 402
Houston, Texas 77036

(Address of principal executive offices)

 

 

 

(713) 988-9252

(Registrant’s telephone number including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ý    No o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).   Yes o   No ý

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

 

Indicate by check mark whether the registrant filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

Yes o   No o

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 7,550,019 shares of common stock.

 

 



 

EXPLANATORY NOTE

 

KMG Chemicals, Inc. (the “Company”) hereby amends its quarterly report on Form 10-Q for the three months ended October 31, 2003 to replace Exhibit 31 with the certifications attached to this Amendment No. 1 to the Company’s Form 10-Q.  Except as described above no other changes have been made to the quarterly report.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

KMG Chemicals, Inc.

 

 

 

 

 

 

 

 

By:

/s/ David L. Hatcher

 

Date:

January 13, 2004

 

David L. Hatcher,

 

 

 

 

President

 

 

 

 

 

 

 

 

 

By:

/s/ John V. Sobchak

 

Date:

January 13, 2004

 

John V. Sobchak,

 

 

 

 

Chief Financial Officer

 

 

 

 

2